EUVIMEDEUVIMED entdecken
Crossref

Long‐acting antipsychotics and mortality in patients with schizophrenia receiving homecare case management

Wen-Yin Chen, Po-Yu Chen, Chih-Chiang Chiu iD, Chun-Hung Pan, Sheng-Siang Su, Chiao-Chicy Chen, Chian-Jue Kuo iD

Psychiatry and Clinical Neurosciences · 2025

DOI: 10.1111/pcn.13853 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Psychiatry and Clinical Neurosciences, 2025. Verfasst von Wen-Yin Chen und 6 weiteren Autor:innen. Beteiligte Einrichtung: Taipei City Psychiatric Center, Taipei City Hospital, Taipei, Taiwan. Hauptthemen laut MEDLINE: Schizophrenia, Antipsychotic Agents, Case Management, Home Care Services. Die Arbeit nennt 30 Literaturangaben. Gefördert von: Taipei City Hospital, Institute for Information Industry, Ministry of Science and Technology, Taiwan.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

Long‐acting injectable antipsychotics (LAIs) offer several advantages over oral antipsychotic medications for treating schizophrenia. However, whether the benefits of LAIs extend to patients receiving homecare case management (CM) remains unclear.

Methods

This cohort study used Taiwan's National Health Insurance Research Database, enrolling 19,680 nationwide patients with schizophrenia who began homecare CM between January 1, 2000, and December 31, 2019. Each patient was followed for 5 years or to the data censored, with 30‐day periods serving as follow‐up units. We evaluated LAI and other medication usage during each period and their associations with mortality outcomes. Additionally, we investigated whether consistent users of homecare CM services (maintenance group) receiving specific LAI treatments had better prognoses.

Results

In the cohort ( n = 19,680), 6428 received first‐generation antipsychotic long‐acting injectables (FGA‐LAIs) and 4954 received second‐generation antipsychotic long‐acting injectables (SGA‐LAIs). The FGA‐LAI group had a mean age of 39.27 years (55.13% male), while the SGA‐LAI group had a mean age of 41.25 years (53.75% male). Of 1366 deaths within 5 years, 980 were from natural causes and 254 from suicide. FGA‐LAIs reduced natural mortality (HR: 0.67, P = 0.001) but increased suicide risk (HR: 1.52, P = 0.01). SGA‐LAIs lowered all‐cause (HR: 0.53, P < 0.001) and natural mortality (HR: 0.42, P < 0.001) without affecting suicide mortality (HR: 0.82, P = 0.384). In the maintenance group, FGA‐LAIs showed no mortality benefit and increased suicide risk (HR: 2.07, P < 0.001), while SGA‐LAIs consistently reduced all‐cause (HR: 0.39, P < 0.001), natural (HR: 0.31, P < 0.001), and suicide mortality (HR: 0.54, P = 0.034).

Conclusions

SGA‐LAIs could be a preferable treatment for reducing mortality in patients with schizophrenia receiving homecare CM, particularly for those in the maintenance group.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SchizophreniaAntipsychotic AgentsCase ManagementHome Care ServicesHumansMaleFemaleAdultMiddle AgedTaiwanDelayed-Action PreparationsCohort Studies

Stichwörter der Autor:innen

antipsychoticscommunity treatmenthomecare case managementmortalityschizophrenia

Substanzen

Antipsychotic AgentsDelayed-Action Preparations

Autor:innen und Institutionen

  • Taipei City Psychiatric Center, Taipei City Hospital, Taipei, Taiwan.
  • School of Medicine, College of Medicine, Fu Jen Catholic University, New Taipei City, Taiwan.
  • Department of Psychiatry, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.
  • Department of Psychology, National Chengchi University, Taipei, Taiwan.
  • Psychiatric Research Center, Taipei Medical University Hospital, Taipei, Taiwan.
  • Department of Psychiatry, Mackay Memorial Hospital, Taipei, Taiwan.

ORCID-Profile: Chih-Chiang Chiu, Chian-Jue Kuo

Förderung

  • Taipei City Hospital
  • Institute for Information Industry, Ministry of Science and Technology, Taiwan

Zitieren

APA

Chen, W. Y., Chen, P. Y., Chiu, C. C., Pan, C. H., Su, S. S., Chen, C. C., & Kuo, C. J. (2025). Long‐acting antipsychotics and mortality in patients with schizophrenia receiving homecare case management. Psychiatry and Clinical Neurosciences. https://doi.org/10.1111/pcn.13853

Vancouver

Chen WY, Chen PY, Chiu CC, Pan CH, Su SS, Chen CC, et al. Long‐acting antipsychotics and mortality in patients with schizophrenia receiving homecare case management. Psychiatry and Clinical Neurosciences. 2025. doi:10.1111/pcn.13853

BibTeX
@article{Chen2025,
  author = {Chen, Wen-Yin and Chen, Po-Yu and Chiu, Chih-Chiang and Pan, Chun-Hung and Su, Sheng-Siang and Chen, Chiao-Chicy and Kuo, Chian-Jue},
  title = {Long‐acting antipsychotics and mortality in patients with schizophrenia receiving homecare case management},
  journal = {Psychiatry and Clinical Neurosciences},
  year = {2025},
  doi = {10.1111/pcn.13853}
}
Kostenlos starten →